{
    "nct_id": "NCT04595838",
    "official_title": "A Randomized, Prospective, Multi-center Trial to Assess the Efficacy of a Cryotherapy Device Versus Best Supportive Oral Care in Mitigating Symptoms of Oral Mucositis in Patients Receiving Chemotherapy for the Treatment of Cancer",
    "inclusion_criteria": "1. Aged 18-80 years\n2. Planned to receive at least 2 cycles of infused stomatotoxic chemotherapy regimens such as:\n\n   * CMF (cyclophosphamide (Cytoxan), methotrexate, 5-FU)\n   * Standard AC+T regimen (doxorubicin (Adriamycin), cyclophosphamide (Cytoxan), Taxane [paclitaxel (Taxol) or docetaxel (Taxotere)]) or any combination of two or more components (e.g., ACT, TAC, TA, AT, AC)\n   * ABVD (doxorubicin (Adriamycin), bleomycin, vinblastine, dacarbazine)\n   * FOLFIRI (irinotecan, 5-FU, leucovorin)\n   * Any other 5-FU-based regimen (excluding FOLFOX)\n3. Be willing and able to complete all study-related activities\n4. Properly obtained written informed consent\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "1. Receiving any oxaliplatin-containing chemotherapy regimen, such as FOLFOX\n2. Concurrent radiotherapy\n3. Unable or unwilling to complete study assessments\n4. Unable or unwilling to avoid using ice chips\n5. Known allergy to silicone\n6. Concurrent participation in another interventional clinical study or use of another investigational agent within 30 days prior to randomization\n7. Any other clinical or psychiatric condition or prior therapy that, in the opinion of the investigator, would make the patient unsuitable for the study or unable to comply with the protocol\n8. Chronic use of opioid analgesics",
    "miscellaneous_criteria": ""
}